Literature DB >> 14663341

Quantitative cerebral blood flow measurements in the rat using a beta-probe and H2 15O.

Bruno Weber1, Nicolas Späth, Matthias Wyss, Damian Wild, Cyrill Burger, Ross Stanley, Alfred Buck.   

Abstract

Beta-probes are a relatively new tool for tracer kinetic studies in animals. They are highly suited to evaluate new positron emission tomography tracers or measure physiologic parameters at rest and after some kind of stimulation or intervention. In many of these experiments, the knowledge of CBF is highly important. Thus, the purpose of this study was to evaluate the method of CBF measurements using a beta-probe and H2 15O. CBF was measured in the barrel cortex of eight rats at baseline and after acetazolamide challenge. Trigeminal nerve stimulation was additionally performed in five animals. In each category, three injections of 250 to 300 MBq H2 15O were performed at 10-minute intervals. Data were analyzed using a standard one-tissue compartment model (K1 = CBF, k2 = CBF/p, where p is the partition coefficient). Values for K1 were 0.35 +/- 0.09, 0.58 +/- 0.16, and 0.49 +/- 0.03 mL x min(-1) x mL(-1) at rest, after acetazolamide challenge, and during trigeminal nerve stimulation, respectively. The corresponding values for k2 were 0.55 +/- 0.12, 0.94 +/- 0.16, and 0.85 +/- 0.12 min(-7), and for p were 0.64 +/- 0.05, 0.61 +/- 0.07, and 0.59 +/- 0.06. The standard deviation of the difference between two successive experiments, a measure for the reproducibility of the method, was 10.1%, 13.0%, and 5.7% for K1, k2, and p, respectively. In summary, beta-probes in conjunction with H2 15O allow the reproducible quantitative measurement of CBF, although some systematic underestimation seems to occur, probably because of partial volume effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14663341     DOI: 10.1097/01.WCB.0000095799.98378.7D

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  7 in total

1.  A two-compartment mathematical model of neuroglial metabolism using [1-(11)C] acetate.

Authors:  Bernard Lanz; Kai Uffmann; Matthias T Wyss; Bruno Weber; Alfred Buck; Rolf Gruetter
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-30       Impact factor: 6.200

2.  Cross-validation of input functions obtained by H₂ 15O PET imaging of rat heart and a blood flow-through detector.

Authors:  Nobuyuki Kudomi; Hannu Sipilä; Anu Autio; Vesa Oikonen; Heidi Liljenbäck; Miikka Tarkia; Jarno Laivola; Jarkko Johansson; Mika Teräs; Anne Roivainen
Journal:  Mol Imaging Biol       Date:  2012-08       Impact factor: 3.488

3.  A probable dual mode of action for both L- and D-lactate neuroprotection in cerebral ischemia.

Authors:  Ximena Castillo; Katia Rosafio; Matthias T Wyss; Konstantin Drandarov; Alfred Buck; Luc Pellerin; Bruno Weber; Lorenz Hirt
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-03       Impact factor: 6.200

4.  NEMA characterization of the SAFIR prototype PET insert.

Authors:  Parisa Khateri; Werner Lustermann; Christian Ritzer; Charalampos Tsoumpas; Günther Dissertori
Journal:  EJNMMI Phys       Date:  2022-06-13

5.  Use of a beta microprobe system to measure arterial input function in PET via an arteriovenous shunt in rats.

Authors:  Geoff Warnock; Mohamed-Ali Bahri; David Goblet; Fabrice Giacomelli; Christian Lemaire; Joel Aerts; Alain Seret; Xavier Langlois; Andre Luxen; Alain Plenevaux
Journal:  EJNMMI Res       Date:  2011-08-10       Impact factor: 3.138

6.  Neuroprotective Effects of Trigeminal Nerve Stimulation in Severe Traumatic Brain Injury.

Authors:  Amrit Chiluwal; Raj K Narayan; Wayne Chaung; Neal Mehan; Ping Wang; Chad E Bouton; Eugene V Golanov; Chunyan Li
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

7.  MicroPET Outperforms Beta-Microprobes in Determining Neuroreceptor Availability under Pharmacological Restriction for Cold Mass Occupancy.

Authors:  Dorien Glorie; Stijn Servaes; Jeroen Verhaeghe; Tine Wyckhuys; Leonie Wyffels; Olivier Vanderveken; Sigrid Stroobants; Steven Staelens
Journal:  Front Neurosci       Date:  2017-02-10       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.